Casdin Capital and Corvex Management’s SPAC CM Life Sciences III prices upsized $480M IPO

CM Life Sciences IIIpricedits upsized $480M IPO of 48M units at $10/unit;; this compares to initial offering of $200M.Each unit consists of one Class A ordinary share and one-fifthof…
Read More